首页/数据集/Exome and tissue-associated microbiota as predictive markers of response to neoadjuvant treatment in locally advanced rectal cancer

Exome and tissue-associated microbiota as predictive markers of response to neoadjuvant treatment in locally advanced rectal cancer

NIAID Data Ecosystem2026-03-13 收录

结直肠癌治疗响应预测

肿瘤微生物组标志物

数据链接：

https://www.ncbi.nlm.nih.gov/bioproject/PRJNA778982 数据链接链接失效反馈

官方服务：

资源简介：

Exome and tissue-associated microbiota as predictive markers of response to neoadjuvant treatment in locally advanced rectal cancer

应用场景：

创建时间：

2021-11-09

肿瘤预后生物标志物

结直肠癌治疗响应预测

Deficiency of the DNA damage repair (DDR) signaling pathways is potentially responsible for genetic instability and oncogenesis in tumors, including colorectal cancer. However, the correlations of mut

NIAID Data Ecosystem70

Radiotherapy and 5-FU resistance in colorectal cancer

肿瘤耐药机制

结直肠癌治疗响应预测

The human colorectal cancer cell line HCT-15 was used to construct the 5-FU-resistant and L-OHO-resistant cell models after radiotherapy. RNA-Seq sequencing was used to compare the differential genes

NIAID Data Ecosystem40

Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer

结直肠癌治疗响应预测

多模态影像组学

Because of metastatic liver cancer of the colon or rectum, patients will be treated with cytotoxic drugs (chemotherapy). In the Radboud University Nijmegen Medical Centre the investigators investigate

NIAID Data Ecosystem20

DNA methylation-based classifier to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal carcinomas.. DNA methylation-based classifier to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal carcinomas.

肿瘤甲基化预测

结直肠癌治疗响应预测

Locally advanced rectal cancer (LARC) patients have been treated with a pre-operative multimodal regimen based on 5-fluorouracil and radiotherapy (nCRT) followed by surgery. Patients that achieve path

NIAID Data Ecosystem50

Treatment Response Prediction System of mCRC Patients Based on CTC

活检技术

结直肠癌治疗响应预测

This study enrolling patients with metastatic colorectal cancer. Detecting CTC at different points in the treatment process. Descripting the molecular atlas of CTC in mCRC patients. Building and valid

NIAID Data Ecosystem30

Exome and tissue-associated microbiota as predictive markers of response to neoadjuvant treatment in locally advanced rectal cancer

资源简介：

相关数据集